You are trooper!
I think it bodes well that if LOXL2 is successful in trials, Pharmaxis should be able to negotiate a decent upfront based on having 2 approved products and 2 Phase II trials with BI.
- Forums
- ASX - By Stock
- SNT
- Ann: Appendix 3B - Grant of Employee Peformance Rights
Ann: Appendix 3B - Grant of Employee Peformance Rights, page-7
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.3¢ |
Change
0.001(3.13%) |
Mkt cap ! $42.58M |
Open | High | Low | Value | Volume |
3.1¢ | 3.4¢ | 3.1¢ | $77.05K | 2.374M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 351201 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 673566 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 351201 | 0.033 |
3 | 520000 | 0.032 |
2 | 247700 | 0.031 |
4 | 1143175 | 0.030 |
7 | 1377931 | 0.029 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 673566 | 1 |
0.035 | 200000 | 1 |
0.036 | 343537 | 2 |
0.039 | 16000 | 1 |
0.040 | 200565 | 2 |
Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |